Luxturna
-
Three Philadelphia Scientists Win 2026 Breakthrough Prize for FDA-Approved Gene Therapy Development
Three Philadelphia scientists were recently named the winners of the 2026 Breakthrough Prize for their work in developing the first FDA-approved gene therapy for a…
-
Glenolden Property Used as a Research Lab Sold to Spark Therapeutics for $6 Million
A Glenolden property once used as a research laboratory for the University of Pennsylvania has been snatched up by Spark Therapeutics for $6 million, writes…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
